跳至主要内容
临床试验/CTRI/2024/05/068042
CTRI/2024/05/068042尚未招募3 期

Efficacy and Safety of Platelet Rich Plasma as an Adjunct Therapy to Split Thickness Skin Graft in Burn Patients with Granulating Raw Wounds - nil

ICMR0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 3 to 20 percentage total body surface area burns at deep second degree and or third degree thermal burns at 10 to 14 days post burns
  • Granulating wound with post burn raw areas
  • Suitable for STSG between 2 to 3 weeks from the burn event as close to day 14 as possible

排除标准

  • Patients unfit for surgery
  • Sepsis and septic shock
  • Multiple organ dysfunction
  • Patient unfit to receive skin graft
  • ß haemolytic Streptococcus infection at the site of application
  • Haemoglobin less than 10gm percentage
  • Serum Albumin less than 2 and half gm per dL
  • Uncontrolled diabetes HbA1c more than 8 percentage
  • Patient follow up not possible based on investigator discretion
  • At 14th post operative day if patient was discharged before day 14
  • At 3 months and 6 months and one year for evaluation of scar
  • Other conditions like
  • Coagulation disorder
  • Patient on systemic steroid use more than 21 days

研究者

发起方
ICMR

相似试验